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Abstract
Background Haloperidol, frequently used for delirium,
can lead to serious side effects, of which QTc prolongation
is the most worrisome since it is associated with an
increased risk of fatal cardiac arrhythmia.
Objectives The aim of this study was to measure the
frequency of haloperidol use after procedures in patients
aged C65 years in a hospital in the Netherlands.
Methods This was a retrospective study among patients
hospitalized in the Netherlands who were aged C65 years
and who underwent a procedure between January 2008 and
January 2009. The hospital’s electronic drug database was
used to identify the use of haloperidol during hospital
admission.
Results A total of 7782 procedures took place in 5946
elderly patients, and 1357 patients were readmitted for a
second procedure in the same year. The overall frequency
of haloperidol use was 5.4 %. Procedures were classified as
elective (90 %) and as major (18 %). A total of 28 % (n =
570) of patients who underwent acute procedures and 24 %
(n = 1086) of patients who underwent major procedures
received haloperidol. Patients receiving haloperidol had a
significantly longer hospital stay (14 vs. 1 day, p\ 0.001)
than patients without haloperidol. Haloperidol users were
more likely to have more than one intervention than non-
users (16.0 vs. 1.7 %, p\ 0.001). In multivariable analy-
sis, haloperidol use was associated with older age (odds
ratio [OR] 1.09; 95 % confidence interval [CI] 1.07–1.11,
p\ 0.001), acute surgery (OR 2.09; 95 % CI 1.65–2.94,
p\ 0.001), and major procedures (OR 15.4; 95 % CI
11.5–21.5, p\ 0.001).
Conclusion We show a frequency of haloperidol use of
5.4 %. Based on this high frequency, surveillance of
adverse events in hospital should be performed systemati-
cally, particularly in the high-risk population that under-
goes acute major surgery.
Key Points
The frequency of haloperidol use among hospitalized
patients in the Netherlands aged C65 years who
underwent a procedure between January 2008 and
January 2009 was over 5 %.
The percentage of haloperidol users is higher in older
patients undergoing acute or major procedures.
Patients using haloperidol experienced a longer
hospital stay in this study and are known to have a
higher risk of adverse events in the literature.
1 Introduction
In 2005, the US FDA warned clinicians against prescribing
antipsychotic medications to patients with dementia-related
psychosis, because it would expose patients to an increased
risk of death [1]. Mittal et al. [2] showed a 1.3 to 2.0-fold
increased risk of stroke and a 1.2 to 1.6-fold increased risk
of mortality; these risk ratios are comparable for all
antipsychotics. Known immediate side effects of antipsy-
chotics include somnolence, urinary tract infection, urinary
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incontinence, extrapyramidal symptoms, or abnormal gait
[3–6]. Antipsychotics are prescribed for many different
symptoms and diseases, such as anxiety, psychosis due to
schizophrenic disease or depression, and behavioral dis-
turbance in dementia or delirium.
Hospitalized patients with delirium may have a
similar or even higher potential for adverse side effects
from antipsychotics than more stable patients. The most
important known risk factors for postoperative delirium
are older age and cognitive or functional impairment
[7]. Many older patients with delirium also have
dementia; they also usually have an acute medical ill-
ness and multiple comorbidities, and are often taking
drugs that increase the QTc interval. Yet this issue
remains unaddressed, because no published, adequately
powered, double-blind, randomized, placebo-controlled
trials have examined the safety of antipsychotics in the
management of delirium [8]. In addition, no specific
recommendations exist for patients with delirium as
well as dementia.
Prevalence estimates for delirium during a hospital
admission are 10–30 %; thus, it is reasonable to assume
that this condition is the single most common cause for the
administration of haloperidol in a hospital setting [9, 10].
The scientific evidence for the efficacy of haloperidol in
treating delirium is based on a few studies [10]. Five
studies evaluated the side effects of haloperidol versus
various neuroleptics (e.g., risperidone, olanzapine, queti-
apine, and ondansetron) and showed no significant differ-
ences in the treatment response for delirium symptoms
[11–15].
The 2010 UK National Institute for Health and Care
Excellence (NICE) guideline on delirium, which took into
account the evidence available at that time, advised lim-
iting the use of antipsychotics for individuals with delir-
ium in distress or at risk to themselves or others.
Furthermore, it should be prescribed only after non-
pharmacological interventions have been tried, and then
only in the lowest possible dose and for the shortest
possible time period [16].
The aim of this study was to measure the frequency
of haloperidol use after procedures in patients aged
C65 years in a hospital in the Netherlands. A prereq-
uisite for assessing the risks associated with antipsy-
chotic use in hospitalized patients is to have systems
that record the use of these drugs. To address the above
gap in the literature, we used electronic pharmacy
records to determine the proportion of hospitalized
patients aged C65 years administered haloperidol after
surgical procedures. We studied haloperidol because it




All patients aged C65 years who underwent a surgical
procedure in the Jeroen Bosch hospital in s–Hertogenbosch
in the Netherlands in the period between 1 January 2008
and 1 January 2009 were included. This hospital has 750
beds and is a non-academic, regional teaching hospital with
21 separate medical training specialties. The surgical spe-
cialties were gynecology, orthopedics, general surgery,
urology, ophthalmology, otorhinolaryngology, oral sur-
gery, neurosurgery, and plastic or reconstructive surgery.
2.2 Study Design
Haloperidol administration during admission was identified
using the electronic hospital drug database. Inclusion cri-
teria included patients who took this medication for at least
1 day during their admission period. In the Netherlands,
the conventional starting dose for haloperidol is 1 mg.
Minor procedures were defined as procedures for which
patients were admitted for less than 6 days, and major
procedures were defined as a stay longer than 6 days.
Procedures were categorized as either acute or elective
based on the reason for admission, as classified by the
International Statistical Classification of Diseases and
Related Health Problems – 9th revision (ICD-9).
2.3 Statistical Analysis
We used the Statistical Package for the Social Sciences
(SPSS, version 19.0, Chicago, IL, USA) for data analysis.
We used t-tests and Mann–Whitney U tests to test for
differences in characteristics in patients with and without
haloperidol use. Variables that were not normally dis-
tributed were expressed as median scores and interquartile
ranges. A two-tailed criterion of p\ 0.05 was considered
statistically significant. We performed univariate and
multivariate logistic regression analyses, where haloperidol
use was the dependent variable, and age, acute versus
elective surgery, minor versus major procedures, and sur-
gical specialty were the independent variables.
3 Results
A total of 7782 procedures occurred in 5946 patients; 145
patients underwent a second procedure during their first
admission, and 1357 patients were admitted for at least one
additional procedure in the same year. The characteristics
of the patients who did and did not use haloperidol are
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presented in Table 1. The overall incidence of haloperidol
use related to the first procedure in the first admission was
5.4 %. Of these, 323 patients (12 %) received haloperidol
throughout the complete admission period. Those admin-
istered haloperidol were significantly older (81.2 vs.
74.4 years, p\ 0.001). In acute procedures (n = 570), the
percentage of haloperidol use was 28.0 versus 3.1 % in the
5376 elective procedures (p\ 0.001). In major procedures
(n = 1086), the percentage was 24.0 versus 1.3 % in 4960
minor procedures (p\ 0.001).
Patients who received haloperidol had a significantly
longer hospital stay (14 vs. 1 day, p\ 0.001) than patients
who did not receive haloperidol. Haloperidol users more
often underwent more than one procedure (e.g., they
underwent two operations or a biopsy followed by an
operation during the admission period [16.0 vs. 1.7 %,
p\ 0.001]) than non-users, but they were less frequently
readmitted for a second procedure (12 vs. 23 %,
p\ 0.001).
An overview of the most common procedures per spe-
cialty is presented in Table 2; 90 % of procedures were
elective and 18 % were major. A total of 29 % of acute
procedures and 45 % of major procedures were performed
in general surgery. Of these, 15 % of patients received
haloperidol. Ophthalmologic surgery was the most frequent
type of surgery (n = 1865; 31.4 %), and the majority of
the ophthalmologic interventions were cataract operations
(89.5 %). These were classified as minor procedures, with
a haloperidol usage of 0.4 %. Haloperidol use in patients
admitted with a fracture was acute: 30 % in surgical
patients and 34 % in orthopedic patients. Haloperidol use
in orthopedics was 6.4 %, in plastic surgery 0.3 %, in
urology 2.4 %, and in gynecology 1.7 %; no patients in the
otorhinolaryngology received haloperidol. The odds ratio
(OR) of haloperidol administration upon second admission
if patients had already been administered haloperidol at
first admission was 55 (95 % confidence interval [CI]
27–116).
Table 3 shows the results of the multivariate analysis.
Haloperidol use was strongly associated with specialty,
specifically general surgery (OR 6.4, 95 % CI 4.0–10.1,
p\ 0.001), acute procedures (OR 1.5, 95 % CI 1.1–2.1,
p\ 0.001), major procedures (OR 8.3, 95 % CI 5.9–11.5,
p\ 0.001), and older age (OR 1.1, 95 % CI 1.08–1.12,
p\ 0.001).
4 Discussion
In this descriptive study of haloperidol use in a hospital
population of surgical patients (N = 5946) treated over the
course of 1 year in a single large hospital in the Nether-
lands, we found an overall frequency of haloperidol
administration of 5.4 %. The hospital is representative of
large teaching hospitals in the Netherlands. Haloperidol use
in acute and major surgery was much higher than in elec-
tive and minor surgery; at least one-quarter of patients who
fell into either category received this drug. The fact that
haloperidol administration was associated with older age,
acute procedures, and major procedures, which are all
Table 1 Characteristics of
patients who did and did not
receive haloperidol
Variables Haloperidol (N = 323) No haloperidol (N = 5623) p value
Age (years) 81.2 (65–101) 74.4 (65–104) \0.001
Male sex (%) 145 ± 45 2409 ± 43 0.47
Specialty (%) \0.001
Ophthalmology 7 ± 2.2 1858 ± 33
General surgery 230 ± 71 1269 ± 23
Orthopedic surgery 66 ± 20 962 ± 17
Plastic surgery 2 ± 0.6 632 ± 11
Urology 14 ± 4.3 578 ± 10
Gynaecology 4 ± 1.2 226 ± 4.0
Otorhinolaryngology 0 ± 0 70 ± 1.2
Othera 0 ± 0 28 ± 0.5
Acute procedure (%) 157 ± 49 413 ± 7.3 \0.001
Major procedure (%) 261 ± 81 825 ± 15 \0.001
Length of stay 14 (2–133) 1 (1–142) \0.001
C1 Intervention (%) 52 ± 16 93 ± 1.7 \0.001
C1 Admission (%) 39 ± 12 1318 ± 23 \0.001
Data are presented as mean ± standard deviation for continuous variables with a normal distribution or as
median (interquartile range) for variables that are not normally distributed
a ‘Other’ includes cardiology, neurosurgery, and oral surgery
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established risk factors for delirium, suggests that delirium
could be the most important indication for its prescription
[18]. However, we do not know the indication of
haloperidol use, and the known risk factors for delirium—
such as operative stress and other drugs used peri- and
postoperatively—are not measured in our database. Fur-
thermore, in our study population, a large group of patients
were ophthalmologic patients (n = 1865), most of whom
underwent a cataract procedure; this type of procedure is
known to have a low delirium prevalence. It is possible that
approximately 0.1 % of patients received haloperidol
1 mg/day prior to procedures if it was known that they had
a medical history of serious delirium.
Indeed, a 5.4 % haloperidol administration level is con-
sistent with the typical delirium rates in these groups, as
reported in the international literature [16, 17]. Additionally,
the multivariate analysis showed that haloperidol use was
associated with longer hospital stay, which might be another
indirect clue that patients who received haloperidol experi-
enced delirium because delirium is known to be associated
with a prolonged hospital stay [19]. Alternatively, the use of
haloperidol itself may have contributed to the length of stay.
More broadly, this study shows that large numbers of
older people received haloperidol during their hospitalisa-
tion for surgery. This level of haloperidol use is
notable given the lack of strong evidence for the benefits of
this drug in the treatment of delirium. No previous study
has investigated the appropriate antipsychotic dosage
levels for delirium, and we believe different countries have
different antipsychotic dosage strategies [9].
Table 2 Characteristics of the
most common surgical
procedures, by specialty
Variables Procedures Acute (%) Major (%) Haloperidol Use
Ophthalmology 1865 1 (0.1) 3 (0.2) 0.4 %
Senile cataract 1670 (89.5 %)
General 1499 430 (29) 674 (45) 15.3 %
Fracture reposition 318 (21.2 %)
Biopsya 240 (16 %)
Digestive tract operations 218 (14.6 %)
Vascular intervention 200 (13.3 %)
Inguinal hernia operation 140 (9.3 %)
Shunt construction 38 (2.5 %)
Orthopedics 1028 110 (11) 250 (24) 6.4 %
Osteoarthrosis surgery 478 (46.5 %)
Fracture reposition 86 (8.4 %)
Removal of plates and correction material 83 (8 %)
Plastic surgery 634 8 (1.3) 16 (2.5) 0.3 %
Hand surgery due to mononeuritis 124 (19.6 %)
Biopsy 36 (5.4 %)
Eye correction surgery 54 (8.5 %)
Other 386 (60.9 %)
Urology 592 15 (2.5) 70 (12) 2.4 %
Urethrocystoscopy 320 (54.1 %)
Prostatectomy 138 (23.3 %)
Biopsy 34 (5.4 %)
Gynecology 230 3 (1.3) 69 (30) 1.7 %
Biopsy 91(39.6 %)
Genital prolapse surgery 78 (33.9 %)
Otorhinolaryngology 70 0 1 (1.4) 0
Sinusitis surgery 20 (28.6 %)
Septum rhinoplasty 8 (11.4 %)
Correction nasal polyp 9 (12.9 %)
Otherb 28 3 (11) 3 (11) 0
a Biopsy in general surgery includes pulmonary biopsy, lymph nodular explorations, benign exploration of
thyroid pathology, rectal polyp excisions, and mamma incision biopsy
b ‘Other’ includes neurosurgery and oral surgery
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Importantly, in the last 10 years, more studies have
identified a number of risks associated with prescribing
antipsychotic drugs during hospital stay, such as a higher
risk of pneumonia [20] and or cerebrovascular events. This
risk is present even during the first week of antipsychotic
use [21]. Furthermore, the initiation of neuroleptics is
associated with a 40 % increased risk of a fracture.
Delirium is known to be a strong risk factor for dementia,
and delirium accelerates cognitive decline in Alzheimer’s
dementia [22, 23]. In light of this, haloperidol should be
prescribed carefully, especially in the absence of scientific
medical evidence.
A key strength of this study is the use of a large hospital
population dataset analyzed over a 1-year period, providing
sufficient power for our study’s conclusions. Additionally,
electronic records are a reliable way to capture medication
use in a hospital setting.
Some limitations should be acknowledged. The study
was retrospective; we did not prospectively collect data on
indications for haloperidol use. Retrospective analysis of
medical charts could yield more relevant information. For
example, indications for prescription, such as behavioral
disorder or psychotic disorder, could not be taken into
account because this detailed information was missing.
Furthermore, the study of adverse events in relation to
haloperidol use was beyond the scope of this study.
Moreover, we limited this study to haloperidol users and
did not investigate other atypical antipsychotics. However,
in the Netherlands, haloperidol is the first medication of
choice for the treatment of delirium in elderly patients in
hospital [17].
5 Conclusion
This study indicates that substantial numbers of older
patients undergoing procedures are prescribed haloperidol,
with an overall frequency of 5.4 %. The highest use is in
older patients undergoing major or acute procedures. This
study is the first study to evaluate the use of haloperidol in
a large hospital population with various surgical proce-
dures. It is important because of the lack of strong positive
evidence in favor of haloperidol use in the treatment of
delirium and/or other indications (e.g., behavioral distur-
bance in dementia), and the potential adverse effects
associated with this drug. Given the large-scale use of
haloperidol, further research on the benefits, side effects,
and costs of this treatment is urgently required.
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